3He J,Gu D,Wu X,et al.Major cause of death among men and women in China[J].N Engl J Med,2005,353:1124-1134.
4Schlittenhardt D,Schober A,Strelau J,et al,Involvement of growth differentiation factor-15/macrophage inhibitory cytokine-1(GDF-15/MIC-1) in oxLDL-induced apoptosis of human macrophages in vitro and in arteriosclerotic lesions[J].Cell Tissue Res,2004,318:325-333.
5Traupe T,Gloekler S,de Marchi SF,et al.Assessment of the human coronary collateral circulation[J].Circulation,2010,122(12):1210-1220.
6Fujita M,Sasayama S.Coronary collateral growth and its therapeutic application to coronary artery disease[J].Circ J,2010,74(7):1283-1289.
7Ran komowski, Fvchs s, leonM, et al. Delivery Strategies to achieve therapeutic myocardial angiogenesis[J]. Circulation. 2000,101:454- 458.
8Boria Fernandez, Alexadra Buehler, Swen Wolfman, et al. Transgenic myocardial overexpression of FGF - 1 increases coronary artery density and branching[J]. Cir Res. 2000,87(3) :207- 213.
9Squires CH, Childs J, Eisenberg SP, et al. Production and characterization of human basic fibroblast growth factor from Eseherichia coil[ J]. J Biol Chem.1988,263(31) : 6297- 6302.
10Banai S, Jaklitsch Mr, Shou M, et al. Angiogenic-induced enhancement of collateral blood flow to ischemic myocardium by vascular endothelial growth factor in dogs[J]. Circulation. 1994,89(5) :2183 - 2189.
